INTRODUCTION
Linagliptin and metformin are regularly prescribed as a fixed drug combination for the treatment type 2 diabetes. Linagliptin assist pancreas to release more insulin and also indicats the liver to stop producing glucose when high glucose level present blood thereby it maintains glucose level of the diabetic patient. Metformin reduces the absorption of glucose from the stomach, bring down the release of stored glucose from the liver. Linagliptin belong to new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs and chemically 1 is 8-[(3R)-3-aminopiperidin-1-yl]-7-(but-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-2, 3, 6, 7-tetrahydro-1 H-purine-2, 6-dione. Metformin 2 chemically N, N-diethyl imido dicarbonimidic diamide hydrochloride and belongs to the biguanide class of anti-diabetic drug. Literature studies reveals that no stability indicating simultaneous RP-HPLC and UV method with degradation studies for titled drug combinations were not reported so far till date with simple solvent system like distilled water. [3] [4] [5] Though LC published article are available, this work stands apart by being simple interms of solvent consumption.Development of method was based upon three different approaches like simultaneous equation,absorbance ratio and absorbances correction method. Moreover LOD and LOQ establishes rapid and sensitive of the developed technique. Robustness study was performed on two different parameters demonstrates method capacity to withstand the deliberate changes. Forced degradation study carried out by UV spectroscopy at four different stress state reveals that method is stable to specified period of time
MATERIAL AND METHOD

Regents and chemicals
Linagliptin and metformin was obtained from Mylan laboratories laboratories limited,hyderbad, India respectively. Formulation was procured from the local market having strength of 2.5 and 500 mg of Linagliptin and metformin respectively. 
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Instrument
Systronics spectrophotometer 2202 UV/Visible double beam spectrophotometer with spectral band width of 2 nm, 0.5 nm of wavelength was used for all spectral measurements using a pair of 1cm matched quartz cell .
Selection of diluents
Diluent suitable for both Linagliptin and metformin was found to be distilled water.Metformin was freely soluble but linagliptin made solubilished in distilled water with vigourous shaking.
Parameter fixations
In the UV region of 400-200 nm, absorption maxima was found to be 230.4 nm and 294.4 nm was for metformin, Linogliptin respectively. Isobestic point for both drugs was chosen at 250.4 nm.
Stock and working solution
A quantity of 50 mg each of Linogliptin, metformin were weighed into a 50 ml separate standard flask and made up to the mark with diluent. From the stock, solution 5 ml was pipetted into 50ml volumetric flask and diluted with the diluents to a get concentration of 100μg/ml. Subsequent dilution was made with diluent to get a concentration of 2-14µg/ ml, 10-40µg/ml for metformin and Linogliptin respectively.
Standard and sample preparation
The developed procedure was extended to formulation of Linogliptin and metformin.Tablets were crushed to a fine powder, powder equivalent to 50 mg was transferred to a 50 ml volumetric flask, dissolved in distilled water and then the solution was made up to the mark with the same and filtered through whatman filter paper no 42. Further dilution are done to get a concentration of 100μg/ml. Subsequent dilutions of this solution were made to a get final concentration of 10 µgl/ml and 40µg/ ml of metformin and Linogliptin respectively for method one and two.
Konari et al.: UV Spectrophotometric Methods on oral hypoglycemic agents
Final dilution for method three 7 was made to get concentration of 3 µgl/ ml and 40µg/ml of metformin and Linogliptin respectively.
Method 1:vierordt's method of simultaneous determination
Where, A 1 and A 2 are absorbance of mixture at 230.4 nm (λ 1 ) and 294.4 nm (λ 2 ) respectively, ax 1 and ax 2 are absorptivities of metformin at λ 1 and λ 2 respectively, ay 1 
Method 3:Absorbance correction method
where A 1 , A 2 are absorbance of mixture at 230.4 nm (λ 1 ) and 294.4 nm (λ 2 ), respectively, ax 1 and ax 2 are absorptivities of metformin at λ 1 and λ 2 , respectively, ay 1 and ay 2 are absorptivities of linagliptin at λ 1 and λ 2 , respectively, c x and c y are concentrations of metformin and linagliptin respectively.
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Forced degradation is a procedure that includes the degradation of drug molecule at different stress conditions that can be used to find out the stability of the drug substance.
Objectives of forced degradation study
To expose the degradation mechanisms at different stress conditions of the drug formulation To check the intrinsic stability of a drug molecule in dosage form To purpose stability indicating nature of a developed techniques
Acidic and Alkaline degradation
From the working solution, 1.4 ml of metformin and 4 ml of linagliptin was taken into separate 10 ml flasks and degradation studies were carried out. 3 ml of 0.1N HCl was added to flasks containing solution of metformin,linagliptin for acidic condition and same procedure repeated with 3ml of 0.1N NaOH for alkaline condition. Then, the volumetric flasks were kept at 60-70ºC in reflux condition 15 minutes in dark for acid and alkaline condition respectively. Finally, volume made up to 10 ml with diluents and absorbance was measured.
Oxidative and thermal degradation
From working solution, transfer 1.4 ml of metformin and 4 ml of linagliptin into separate flask and to each 1ml of 6 % w/v of hydrogen peroxide was added and the volume was made up to 10 ml the mark with diluent. Then, the volumetric flasks were kept in dark for 15 min and absorbance was measured. Thermal study was carried out by taking 1.4 ml of metformin and 4 ml of linagliptin from working solution into separate flasks 10 ml flask. Then kept in hot air oven at 90ºC for 15 min and vol was made up to 10 ml with diluents and absorbance was measured.
Method Validation
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Accuracy
The accuracy of the method was determined by preparing solutions at different concentrations such as 80%, 100% and 120% in which the amount of formulation was kept constant and the amount of pure drug was varied at three different levels. The solutions were prepared in triplicates and the accuracy was indicated by percentage of recovered amount of drug.
Precision
Precision studies were performed for intermediate/ruggdness and intraday. Ruggdness were carried out by using different UV instrument. Aliquot portions of stock solution of both drug was further diluted to get concentration of 2,10µg/ml for metformin and for linagliptin 10,40µg/ ml.
Linearity
Linearity was established in the range of 2-14 µg/ml for metformin and 10-40 µg/ml of linagliptin. The correlation coefficient of the linearity was found to be 0.999 at each wavelength for both drugs. Residual plot displayed excellent linearity.
Stability of analytical solution
The stability of analytical solution for the standard and sample preparation was determined by taking the absorbances at 4, 8, 12, 24 and 48 h.
Specificity study
Specificity study was conducted by comparing the spectrum of tablet solution and that of standard solution. It was noted that there was no interference of the excipients in the formulations. Forced degradation studies also confirms the specificity of the developed method.
Robustness study
It was conducted by the minor variations in the optimized parameters like pH of solvent system and the absorption maxima of the determination. It was observed that there were no much changes in the absorption value of the two titled drugs.
LOD and LOQ
LOD is the lowest amount of analyte in a sample that can be detected, but not necessarily quantitated under the optimized conditions. Limit of detection can be calculated using the following equation as per ICH guidelines. Average mean of six determinations LOD = 3.3 × F/S F = Standard deviation of the response, S = Slope of the corresponding calibration curve. LOQ is the lowest concentration of analyte in a sample that can be determined with the acceptable precision and accuracy under optimized conditions. Limit of quantification can be calculated using the following equation as per ICH guidelines. LOQ = 10 × F/S F = Standard deviation of the response, S = Slope of the corresponding calibration curve.
RESULT
Forced degradation studies
Metformin degraded up to 19.72 % that was slightly high in contrast to linagliptin under acidic condtion whereas as in alkali condition linagliptin degraded little more than metformin. Moreover Slight shift of lamda max was detected for linagliptin under alkaline forced degradation study.This may be due to break down of ionsiable functional group present in the titled drug molecule.linagliptin undergone high degradation under peroxide stress condition in comparision to metformin and may be due electron transfer mechanism to form reactive cations and anions. Thermal degradation explained on the basis of arrhenius equation and linagliptin was slightly sensitive to thermal conditions.forced degradation studies proves that these methods are apt for its proposed use. Forced degradation results can be used for the development of stable formulation and helps in designing proper storage requirement (Table 1 & Figure 1 ,2).
Optimization and validation of method
Three methods were used for the estimation of metformin and linagliptin in pharmaceutical dosage form with a simple solvent system (Table 2 & Figure 3, 4) .Validation studies were carried out on different parameters Konari et al.: UV Spectrophotometric Methods on oral hypoglycemic agents (Figure 5, 6 ).
Accuracy or recovery conducted at three different levels (Table 3) . Intra and Inter day precision were carried out using same optimized conditions and and RSD [15] [16] was less than 2 % (Table 4) . LOD and LOQ indicate that method was highly sensitive and fast (Table 5 ). The method was found highly specific since there is no interference form the excipients of the formulations. Analytical solution was found stable up to 48 hrs on stable storage condition.The method has been highly robust since deliberate changes in the optimized parameters does not effect to a certain extent (Table 6 ). 
CONCULSION
The developed spectroscopic methods are found to be rapid, cost effective, accurate and precise and can be used for routine analysis of metformin and linagliptin. The developed methods were validated as per ICH guidelines. The % RSD for the validation parameters was found to be less than 2%. Hence proposed method may be used for routine analysis of these drugs in pharmaceutical dosage forms. Stability indicating nature of the method well established for a specified period which indirectly point out the method competence under different stress condition and thereby useful for the designing of storage requirement of the formulation. This work can be extended to characterize unknown degradents with integrated approach.
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